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RESUMO.- [Estudo comparativo do eletrorretinograma
de campo total em cães diabéticos e não diabéticos com
catarata.] Catarata madura e hipermadura, alteração frequen-
temente observada em cães, impossibilita a visibilização
do fundo do olho e provável diagnóstico de degenerações
retinianas. Objetivou-se comparar as respostas retiniana de
cães diabéticos e não diabéticos, ambos portadores de ca-
tarata madura ou hipermadura, com auxílio do eletrorretino-
grama de campo total, utilizando o protocolo da International
Society for Clinical Electrophysiology of Vision. Sessenta e
seis cães, com idades variando entre 6 a 15 anos de idade
foram divididos em dois grupos: (1) CG, cães não diabéti-
cos com catarata madura ou hipermadura e (2) DG, cães
diabéticos com catarata madura ou hipermadura. Mensurou-
se amplitude pico a pico (microvolts) e tempo de culmina-
ção da onda-b (milisegundos) para as cinco respostas do
ERG (resposta de bastonetes, máxima resposta, potencial
oscilatório, resposta de cones e flicker a 30Hz). Avaliando-
se as respostas obtidas com o exame, o grupo de cães
diabéticos apresentou menor amplitude e maior tempo de
culminação da onda-b em todas as respostas. O aumento
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Being the commonest ocular disorder, dense cataracts disable fundoscopic examination
and the diagnosis of retinal disorders, which dogs may be predisposed. The aim of this
study was to compare the electroretinographic responses recorded according to the
International Society for Clinical Electrophysiology of Vision human protocol to evaluate
retinal function of diabetic and non diabetic dogs, both presenting mature or hypermature
cataracts. Full-field electroretinogram was recorded from 66 dogs, with ages varying from 6
to 15 years old allocated into two groups: (1) CG, non diabetic cataractous dogs, and (2) DG,
diabetic cataractous dogs. Mean peak-to-peak amplitude (microvolts) and b-wave implicit
time (milliseconds) were determined for each of the five standard full-field ERG responses
(rod response, maximal response, oscillatory potentials, single-flash cone response and 30
Hz flicker).  Comparing CG to DG, ERGs recorded from diabetic dogs presented lower
amplitude and prolonged b-wave implicit time in all ERG responses. Prolonged b-wave implicit
time was statistically significant (p< 0.05) at 30 Hz flicker (24.0 ms versus 22.4 ms). These
data suggests full-field ERG is capable to record sensible alterations, such as flicker’s
implicit time, being useful to investigate retinal dysfunction in diabetic dogs.
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do tempo de culminação da onda-b em DG foi estatistica-
mente significante (p<0.05) no flicker a 30 Hz (24.0ms versus
22.4ms). ERG de campo total é capaz de registrar altera-
ções em respostas sensíveis como o tempo de culminação
da onda-b do flicker, podendo ser útil para investigar
retinopatias em cães diabéticos.
TERMOS DE INDEXAÇÃO: Eletrorretinograma, cão, catarata,
diabetes mellitus,  retinopatia diabética, retina.
INTRODUCTION
Diabetes mellitus (DM) is one of the most frequent disorders
of endocrine pancreas in dogs and cats. The most common
forms of diabetes vary with the species. In dogs, the com-
monest is Type 1, characterized by pancreatic â-cell
destruction, which leads to absolute insulin deficiency
(insulin-dependent diabetes mellitus) (Rand et al. 2004).
DM induces several ophthalmic disorders, being
cataracts of acute onset, rapidly progressive and bilaterally
symmetrical, the commonest ocular manifestation resulting
blindness (Cullen & Webb 2007, Ofri 2008). Lens-induced
uveitis (LIU), lens capsule rupture, glaucoma and lens
luxation may also be observed (Wilkie et al. 2006). Cataract
extraction by phacoemulsification is the treatment of choice,
recovering vision and preventing complications (Wilkie &
Colitz 2007). Prior to surgery, several tests can be required
aiming to predict full visual restoration; one of these is the
full-field electroretinogram (ERG) (Rubin 1971).
ERG is an objective electrodiagnostic method (Tzecov
& Arden 1999, Safatle et al. 2005) utilized to evaluate retinal
function.  Early detection of dysfunction at retinal external
layers, even earlier than the appearance of clinical signs is
commonly observed in this test (Komaromy et al. 1998).
This exam has already shown itself of great importance in
small animals, although it can also be used in large
(Komaromy et al. 2003) and exotic animals (Hendrix & Sims
2004). In dogs, ERG is mostly utilized for preoperative
evaluation of patients presenting cataracts, for the
characterization of disturbances causing blindness
(Ekesten 2007) like glaucoma, achromatopsia (Rubin 1971,
Hurn et al. 2003), retinal dysplasias, degenerative
retinopathies (Safatle et al. 2005), optic nerve hypoplasia,
sudden acquired retinal degeneration syndrome or neuronal
ceroid lipofuscinoses (Narfström 2006), besides its use in
dogs as animal models for scientific protocols (Petersen-
Jones et al. 2006).
Nowadays, the most performed ERG protocol in animals
was suggested by the European College of Veterinary
Ophthalmology (ECVO) in 2002 and consists on 4 distinct
responses (rod, maximal, cones and flicker response)
(Narfström et al. 2002). In human medicine, an extra response
is recorded: the oscillatory potential. This specific response
originates from the interaction of the amacrine, ganglionic
and bipolar cells (Nusinowitz & Heckenlively 2006). Any
reduction in this specific response may indicate retinal
ischemia that is commonly observed in diabetic human
patients with diabetic retinopathy (DR) (Kim et al. 1998). In
1989, the International Society for Clinical Electrophysiology
of Vision (ISCEV) defined a human standard ERG protocol,
in which those 5 recorded responses are obtained through a
fully dilated pupil after thirty minutes of dark adaptation
(Maehara et al. 2005).
The purpose of this study was to compare the full-field
electroretinogram in diabetic and non diabetic dogs, both
presenting mature or hypermature cataracts according to
the ISCEV human standard ERG protocol.
MATERIALS AND METHODS
Dogs referred to the Veterinary Hospital of the School of
Veterinary Medicine of the São Paulo University from 2006 to
2008 were included in this study according to the following
criteria: diabetic and non diabetic dogs should present mature
or hypermature cataracts, and no other systemic or ophthal-
mologic disorder.
Complete ophthalmological, clinical (including blood
screen) and heart exams (electrocardiogram and arterial
pressure measurement) were preformed in each subject.
Ophthalmologic examinations included Schirmer tear test5,
fluorescein stain6, applanation tonometry7, slit lamp biomicros-
copy8 and ocular ultrasound9.
After all the ophthalmic workup, sixty six dogs with ages
varying from 6 to 15 years old (yo) were selected than, twenty
nine were non diabetic dogs with cataracts (18 males and 11
females), and thirty seven were diabetic dogs (7 males and 30
females).
Studied breeds were: Mixed Breed dogs(23), Miniature
Poodles(19), Brazilian Terriers(3), German Shepherds(3),
Bichon Frisès (2), Malteses (2), Pinschers (2), Beagle(1), English
Cocker Spaniel(1), Labrador Retriever(1), Lhasa Apso(1),
Miniature Schnauzer(1), Pit Bull(1), Rottweiller(1), Sheepdog (1),
Siberian Husky(1), Teckel(1), Weimaraner(1) and Yorkshire
Terrier(1).
Animals were allocated in two groups: Cataract Group
(CG) and Diabetic Group (DG) and were studied according
to the Bioethics Committee of the institution, protocol n. 06/
2001.
Subjects’ preparation for ERG. All subjects were fasted for
at least 8 hours before ERG testing. Maximal pupillary dilation
was obtained using one eye drop of 1% tropicamide10, followed
by 1 drop of 10% phenylephrine hydrochloride11 at least 30
minutes prior to the ERG session.
Sedation protocol and dark adaptation. Dogs were pre-
medicated with subcutaneous 0.044 mg/kg of atropine sulfate12.
Eyes were dark adapted with occlusive bandage for 30 minutes.
The sedation was performed with 0.5 mg/kg xylasine
5 Teste de Schirmer®, Ophthalmos Ind. Farmacêutica, São Paulo,
SP, Brazil.
6 Fluoresceína strips®, Ophthalmos Ind. Farmacêutica, São Paulo,
SP, Brazil.
7 Tono-pen.XL, BIO-RAD, Hercules, CA, USA.
8 SL-14, Kowa Optimed Incorporation, Torrance, CA, USA.
9 Accutome B-Scan Plus, Accutome Incorporation, Malvern, PA, USA.
10 Mydriacyl 1%®, Alcon Labs. do Brasil Ltda., São Paulo, SP, Brazil.
11 Fenilefrina 10%®, Allergan Produtos farmacêuticos Ltda., São
Paulo, SP, Brazil.
12 Atropion 0.50 mg ®, Ariston, São Paulo, SP, Brazil.
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hydrochloride13 and 0.2 mg/kg butorphanol14. Subcutaneous 4
mg/kg lydocaine15 was administered at the caudal lateral canthi
of both eyelids to avoid palpebral movements.
ERG procedure. Electroretinograms were recorded from
both eyes using the 2000 Veris System16.
A bipolar contact lens electrode17 was placed on both
corneas after 2% methylcellulose eyedrops instillation18 to
improve electrical contact and to protect ocular surfaces. Topical
0.5% proxymetacaine hydrochloride eyedrops19 was utilized to
anesthetize both corneas. A ground electrode20 was filled with
electrolytic gel and was placed at the earlobe, after its clipping
and cleaning.
Patients were positioned in sternal recumbency while their
whole heads were introduced inside the Ganzfeld stimulator.
Third eyelid protrusion and bulb rotation were avoided and the
eyes were kept centralized during the procedure.
ERG was simultaneously recorded from both eyes in a dark
room, according to the ISCEV standard protocol, constituted of
five responses: (1)  a maximal intensity white light attenuated
by a 2.4 log neutral density filter to elicit a dark-adapted rod
response; (2) a maximal intensity white light to elicit a mixed
dark-adapted rod and cone response; (3) the maximal intensity
white light with a 100 Hz low-cut and 1 KHz high-cut filter to
elicit oscillatory potentials; - the maximal intensity white light on
a 30cd/m2 background presented; (4) 1 Hz; and (5) 30 Hz to
elicit cone responses. A period of 10min was allowed to adapt
to the background light when collecting the cone responses.
13 Xilazin 2%®, Syntec, Hortolândia, SP, Brazil.
14 Torbugesic 10 mg®, Fort Dodge, Campinas, SP, Brazil.
15 Xylestesin 2%®, Cristália, Itapira, SP, Brazil.
16 ElectroDiagnostic Imaging Inc., San Mateo, USA.
17 Burian Allen Electrode, Electro-Diagnostic Imaging, Inc., San Mateo,
CA, USA.
18 Metilcelulose 2%®, Ophthalmos Ind. Farmacêutica, São Paulo,
SP, Brazil.
19 Anestalcon 0.5%®, Alcon Labs do Brasil Ltda, São Paulo, SP,
Brazil.
20 Gold Disc Electrode in Ear Clip, Grass Instrument Division, Astro
Med. Inc., West Warwick, RI, USA.
Fig.1. ERG waveforms obtained from three non diabetic dogs (a);(b);(c) with mature or hypermature
cataracts according to ISCEV protocol.
Twenty responses were computer-averaged for each step of
the standard protocol, except for the 30 Hz flicker for which 50
responses were averaged.
After presenting standard dark- and light-adapted stimuli,
each response was analyzed for a- and b-wave amplitude and
implicit time. ERG parameters were measured from peak-to-
peak amplitudes differences: from the negative peak of the a-
wave to the positive peak of the b-wave, in microvolts (ìV); and
implicit times, from the light onset to the positive peak of the b-
wave, in milliseconds (ms).
Full-field ERG testing sessions had as long as approxima-
tely 60 minutes, being the first thirty minutes spent for dark
adaptation, and ten minutes for light adaptation.
Data analysis. For statistical analysis, only ERG recordings
presenting little or none interference from one eye of each
subject were chosen. Unpaired t test was performed to test the
difference in means; when data failed Levene’s test for equality
of variances, a t test with Welch correction was performed.
Statistically significance differences were established at
levels of p<0.05. SPSS software (version 16.0 for Windows,
SPSS Inc.), was utilized to perform all statistical analysis.
RESULTS
All 5 standardized full-field ERG responses were successfully
recorded in all subjects. Representative ERG waveforms
obtained from 3 CG dogs and 3 DG dogs are shown in Figu-
re 1 and 2.
Overall, mean peak to peak amplitudes seemed to be
smaller for each of the five standard protocol steps in DG
when compared to CG, but these findings had not reached
statistical significance. 30 Hz flicker presented statistically
prolonged b-wave implicit times (p< 0.05) in diabetic animals
with cataracts when compared to CG (24.0ms versus
22.4ms).
Table 1 shows mean amplitudes (measured peak-to-peak
from a-wave to b-wave) and respective standard deviations
and implicit times for rod, maximal response, cone, flicker
responses (average of sinusoidal peak-to-peak responses)
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and oscillatory potentials obtained from the two groups. These
results are plotted, respectively, in Figure 3 and 4.
DISCUSSION
Being the commonest ocular disorder, dense cataracts
disable fundoscopic examination and the diagnosis of retinal
disorders, which dogs may be predisposed. Full-field ERG,
one of the most required exams before cataract extraction,
should be required for being capable to detect retinal function
abnormalities in diabetic dogs, which could contra-indicate
surgery.
ERG recordings are influenced by many factors, such
as pupil size, dark adaptation time, electrodes, stimulus
intensity, age, breed (Hérbert et al. 1996, Marmor et al.
Table 1. Standard full-field ERG mean peak-to-
peak amplitudes  and b-wave implicit times
from the 2 groups (66 dogs)
Mean (standard deviation)
CG (29 dogs) DG (37 dogs)
Age (years) 10.0 (2.6) 10.2 (1.8)
Amplitude (ìV)
Rod response 52.4 (24.8) 50.5 (20.5)
Maximal response 73.6 (35.5) 72.5 (29.0)
Oscillatory potential 7.9 (4.4) 7.4 (3.7)
Cone response 15.1 (9.3) 14.1 (7.2)
Flicker response 8.2 (3.9) 7.2 (5.0)
Implicit time (ms)
Rod response 54.5 (7.0) 56.5 (6.6)
Maximal response 31.0 (2.7) 31.9 (2.0)
Cone response 29.8 (1.5) 30.7 (3.7)
Flicker response 22.4 (1.4) 24.0 (3.8)
Fig.2. ERG waveforms obtained from three diabetic dogs (d);(e);(f) with mature or hypermature cataracts
according to ISCEV protocol.
Fig.4. Mean b-wave implicit times and respective standard
deviations for rod, maximal, cone and 30 Hz flicker
responses obtained from the 2 groups. m- = P<0.05 vs CG.
Fig.3. Mean peak-to-peak amplitudes and respective standard
deviations for rod, maximal, cone, 30 Hz flicker responses
(average of sinusoidal peak-to-peak responses) and
oscillatory potentials from the 2 groups. m- = P<0.05 vs CG.
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2004, Nusinowitz & Heckenlively 2006, Petersen-Jones et
al. 2006, Ekesten 2007) or intraocular diseases, such as
cataracts, lens-induced uveitis (Maehara et al. 2007),
glaucoma (Ofri et al. 1993) retinal hereditary degenerations
(Safatle et al. 2005) or diabetic retinopathy (Bresnick &
Palta 1987, Layton et al. 2007). In this survey, studied
animals did not present any other systemic or ophthalmic
disorder then diabetes and mature or hypermature cataracts;
each subject was submitted to the same protocol, including
dark adaptation time, electrodes, ERG machine, stimulus
intensity, sedation protocol and fully pupil dilatation.
Dogs ages from both groups were very similar (medium
age: 10.0 yo at CG and 10.2 yo at DG). Despite each group
have presented different breeds, most common studied
breeds were Miniature Poodle (14 at CG and 5 at DG) and
Mixed Breed dogs (7 at CG and 16 at DG). Labrador
Retrievers, Schnauzer Terriers and Pugs were referred as
predisposed breeds to develop diabetic cataracts (Landry
et al. 2004). Other breeds, such as brachycephalic dogs
and Shar Pei may also be predisposed to this disorder,
because of their difficulty to maintain glucose levels during
insulin therapy (Bean et al. 1999). Studied Labrador
Retriever and the Schnauzer Terrier were diabetic dogs,
but different from other studies just one brachycephalic
dog (Lhasa Apso) was observed.
Female dogs were present in a 4:1 proportion to male
dogs. Recent studies have shown a decrease in this
proportion during the last 20 years (Davidson et al. 2005)
what was not observed in this assay.
Cataracts act as a filter that reduces stimulus strength.
Therefore, both groups presented cataracts in advanced
stage (mature or hypermature). ERG values can also be
influenced by lens induced uveitis (LIU) (Maehara et al.
2007), as so, any of the studied dogs presented
ophthalmologic alterations, such as red eyes, miosis, low
intraocular pressure or other abnormality observed during
ocular ultrasound examination that could justify altered
values.
Dogs are predisposed to retinal degenerations. Breeds
like Miniature Poodle usually present its disease around 5
yo. Studied animals presented medium age of 10.0 yo and
alterated ERG recordings that could suggest such
degenerations were excluded from the study (Narfström &
Petersen-Jones 2007).
Amplitude reductions and timing delays of various
components of the electroretinogram have been reported
frequently in diabetic persons presenting diabetic
retinopathy (DR) and could be related both to retinopathy
severity and to the rate of retinopathy progression. On its
early stages, timing delays may be more expected than
amplitude reduction in human DR, because timing delays
precede amplitude reduction, what was already confirmed
at maximal and flicker responses (Bresnick & Palta 1987).
These timing delays in the retina could be compared with
the conduction delays described elsewhere in the nervous
system in diabetes. Several studies have described
conduction delays in others electrophysiological tests in
DM patients, such as prolonged peripheral nerve conduction
velocities and visual evoked cortical potential latencies
(Puvanendran et al. 1983, Parisi et al. 1997). This study
showed similar results, once amplitude reduction and timing
delays of all components of the ERG were observed and
flicker’s timing delays were statistically significant.
Amplitude of oscillatory potentials was found lower in
DG when compared to CG, but this alteration was not
statistically significant. A reduction in this specific response
may indicate retinal ischemia, suggesting the DR diagnose
in human patients (Tzecov & Arden 1999). Oscillatory
potentials can also be useful for predicting DR progression
and be well correlated with its severity (Tzecov & Arden
1999, Layton et al. 2007). These changes were present in
56.75% (21 of 37 dogs presented values above mean
values) of the diabetic dogs.
DR (spontaneous and experimental) was already
diagnosed in diabetic dogs, and may be observed by
fundoscopic examination as microaneurysms, retinal
hemorrhages, tortuous and dilated retinal vessels, hyper-
reflectivity of tapetal area, and chorioretinal exudates,
similarly with the beginning of the human diabetic retinopathy
(Muñana 1995). Otherwise, retinal abnormalities in dogs
are generally impossible to observe by fundoscopic
examination because of cataracts, making necessary the
utilization of other exams such as full-field ERG and ocular
ultrasonography.
Besides DR, retinal bleeding can also be induced by
systemic arterial hypertension, immune mediated diseases,
thrombocytopenia, coagulopathies, infection and hyper
viscosity syndrome, leading to rapid retinal lesions (Cullen
& Webb 2007). None of the studied dogs presented any
systemic disease that could justify alterations on ERG res-
ponses.
In dogs with spontaneous diabetes, DR takes approxi-
mately 3 to 5 years to develop, whereas in dogs with expe-
rimental diabetes it might take almost 2 years (Cullen &
Webb 2007). In this study, just 3 dogs had diabetes for
more than 3 years and 9 had the disease for at least 1
year. Either way, ERG changes could be detected by this
exam. Similar observation was already found in ERGs
recorded from children with insulin-dependent diabetes
mellitus that did not present any fundoscopic or fluorescein
angiography alteration that could confirm DR at the time
that ERG was recorded, but developed the disease some
time later, suggesting that ERG is capable to detect early
DR alterations, even before the appearance of other
symptoms (Tzecov & Arden 1999).
Authors suggests that more studies should be perfor-
med to diagnose DR in dogs after ERG examination, such
as fundoscopic examination after cataracts removal or
retinal histopathology, where thickening of basement
membrane in retinal capillaries, dilation of retinal veins, loss
of pericytes, microaneurysms, and areas of capillary no
perfusion may be observed (Landry et al. 2004).
In conclusion, full-field ERGs were successfully obtained
from non diabetic and diabetic dogs, both presenting mature
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or hypermature cataracts. Flicker timing was statistically
altered in diabetic dogs, suggesting that this alteration may
predict nerve conduction delays, what may be seen at
retinal vascular abnormalities.
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